{
  "id": 15353937,
  "title": "Standex director Thomas Chorman sells $13,569 in stock",
  "url": "https://urgent.news/2026/10/18/standex-director-thomas-chorman-sells-13-569-in-stock",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-18T04:31:13.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/standex-director-thomas-chorman-sells-13569-in-stock-93CH-4955769"
  },
  "original_language": "en",
  "account": "Director Thomas E. Chorman of Standex International Corp. (SXI) sold 50 shares of the company's common stock on October 1, 2026. The transaction was valued at $13,569, with each share being sold at $271.39. This sale was conducted under an existing 10b5-1 trading plan, which was put in place on November 6, 2025. As a result of this transaction, Mr. Chorman now owns 12,266 shares of Standex International Corp. common stock. Standex, with a market capitalization of $3.21 billion, is trading above its InvestingPro Fair Value, indicating that the stock might be overvalued at present. The company has a history of paying dividends for 56 consecutive years, showcasing a commitment to returning value to shareholders. For a more in-depth analysis, a Pro Research Report on SXI is available, providing expert insights into this dividend stalwart. Recently, Standex International reported adjusted earnings of $2.45 per share on revenue of $228.25 million for its fiscal fourth quarter of 2026, slightly beating Wall Street's expectations. The company also expressed optimism for fiscal 2027, highlighting growth opportunities in electronics, aerospace, and grid infrastructure. Following the earnings release, investment firm DA Davidson raised its price target for Standex to $350 from $323, maintaining a Buy rating based on the company's growth prospects. JPMorgan, meanwhile, initiated coverage on Standex with a Neutral rating and a price target of $320, suggesting a potential 10% upside from the current price. These developments offer investors valuable insights into Standex's recent activities and its projected growth trajectory.",
  "summary": null,
  "key_points": [
    "Thomas Chorman sold 50 SXI shares for $13,569 on Oct 1, 2026",
    "Sale executed under 10b5-1 plan since Nov 6, 2025",
    "Standex trading above fair value with 56-year dividend history"
  ],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}